Stockscreener 앱 받기
2.77
4.53%
0.12
시간 외 거래:
2.75
-0.02
-0.72%
전일 마감가:
$2.65
열려 있는:
$2.84
하루 거래량:
1.50M
Relative Volume:
1.12
시가총액:
$183.17M
수익:
$69.23M
순이익/손실:
$-33.10M
주가수익비율:
-2.3475
EPS:
-1.18
순현금흐름:
$-39.26M
1주 성능:
-10.36%
1개월 성능:
-2.81%
6개월 성능:
-39.52%
1년 성능:
+168.93%
1일 변동 폭
$2.685
$2.87
1주일 범위
$2.61
$3.135
52주 변동 폭
$0.52
$5.92
Neuronetics Inc Stock (STIM) Company Profile
명칭
Neuronetics Inc
전화
877-600-7555
주소
3222 PHOENIXVILLE PIKE, MALVERN, PA
STIM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
2.77 | 175.23M | 69.23M | -33.10M | -39.26M | -1.18 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-10-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2018-07-24 | 개시 | Canaccord Genuity | Buy |
모두보기
Neuronetics Inc 주식(STIM)의 최신 뉴스
Will Neuronetics Inc. continue its uptrendVolume Spike & Precise Buy Zone Identification - newser.com
Neuronetics Inc (STIM) Q3 2025: Everything You Need To Know Ahea - GuruFocus
Neuronetics Inc (STIM) Q3 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Real time alert setup for Neuronetics Inc. performanceJuly 2025 Breakouts & Weekly Setup with High ROI Potential - newser.com
Tools to monitor Neuronetics Inc. recovery probability2025 Market Overview & AI Forecast for Swing Trade Picks - newser.com
Will Neuronetics Inc. bounce back from current supportWeekly Profit Report & High Return Trade Guides - newser.com
Neuronetics reports inducement grant - Medical Buyer
Is Neuronetics Inc. (NRC) stock a buy before earnings results2025 Geopolitical Influence & Growth Focused Entry Reports - newser.com
Why Neuronetics Inc. stock remains on watchlistsJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - newser.com
What does recent volatility data suggest for Neuronetics Inc.2025 Earnings Impact & Reliable Breakout Stock Forecasts - newser.com
Sentiment analysis tools applied to Neuronetics Inc.2025 Price Targets & Real-Time Price Movement Reports - newser.com
Can trapped investors hope for a rebound in Neuronetics Inc.Market Performance Summary & Fast Moving Stock Watchlists - newser.com
Neuronetics Inc. stock trend forecast2025 Valuation Update & Growth-Oriented Investment Plans - newser.com
Is Neuronetics Inc. stock attractive for long term wealth buildingWeekly Profit Analysis & Growth Focused Investment Plans - newser.com
Detecting support and resistance levels for Neuronetics Inc.July 2025 Summary & Free Technical Confirmation Trade Alerts - newser.com
Will Neuronetics Inc. stock maintain dividend yieldWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Analyzing net buyer seller activity in Neuronetics Inc.July 2025 Institutional & Verified Trade Idea Suggestions - newser.com
Is Neuronetics Inc. stock a top momentum playJuly 2025 Earnings & Trade Opportunity Analysis - newser.com
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
Neuronetics (NASDAQ: STIM) grants 38,850 RSUs to 12 employees under Nasdaq 5635(c)(4) - Stock Titan
Exit strategy if you’re trapped in Neuronetics Inc.2025 Trading Volume Trends & Comprehensive Market Scan Insights - newser.com
Will Neuronetics Inc. stock maintain growth storyJuly 2025 Outlook & Fast Exit/Entry Strategy Plans - newser.com
Neuronetics signs exclusive TMS device agreement with Elite DNA - Investing.com
Neuronetics signs exclusive TMS device agreement with Elite DNA By Investing.com - Investing.com Canada
Neuronetics (STIM) Secures Exclusive Deal with Elite DNA Behavio - GuruFocus
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence - The Manila Times
Neuronetics (NASDAQ: STIM) sole TMS provider to Elite DNA’s 30+ sites in 3‑year pact - Stock Titan
Neuronetics Inc (STIM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.84%
0.40%
자본화:
|
볼륨(24시간):